Indole-type derivatives as inhibitors of p38 kinase

Details Indole-type derivatives as inhibitors of p38 kinase Indole-type derivatives as inhibitors of p38 kinase

2005-03-08

2005-03-08

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S367000, C544S370000, C544S373000

Reexamination Certificate

active

06864260

ABSTRACT:
The invention is directed to methods to inhibit p38-α kinase using compounds which contain a phenyl group linked through a piperazine ring to a substituted indole.

REFERENCES:
patent: 3316260 (1967-04-01), Shen et al.
patent: 4088765 (1978-05-01), Winn et al.
patent: 4243806 (1981-01-01), Raeymaekers et al.
patent: 4454130 (1984-06-01), Tominaga et al.
patent: 4737501 (1988-04-01), Tominago et al.
patent: 4886809 (1989-12-01), Tamada et al.
patent: 5409941 (1995-04-01), Nowakowski
patent: 5462934 (1995-10-01), Goto et al.
patent: 5696122 (1997-12-01), Gaster et al.
patent: 5698553 (1997-12-01), Prucher et al.
patent: 5714498 (1998-02-01), Kulagowski et al.
patent: 5726177 (1998-03-01), Italazy et al.
patent: 5795907 (1998-08-01), Kalindjain
patent: 6340685 (2002-01-01), Mavunkel
patent: 20030092717 (2003-05-01), Dugar et al.
patent: 0 318 235 (1989-05-01), None
patent: 0 431 945 (1991-06-01), None
patent: 0 709 384 (1996-05-01), None
patent: 0 831 090 (1998-03-01), None
patent: 2-184673 (1990-07-01), None
patent: 3-161-470 (1991-07-01), None
patent: 9-124631 (1997-09-01), None
patent: WO 9640143 (1996-12-01), None
patent: WO 9726252 (1997-07-01), None
patent: WO 9806715 (1998-02-01), None
patent: WO 9807425 (1998-02-01), None
patent: WO 9828292 (1998-07-01), None
patent: WO 9900357 (1999-01-01), None
patent: WO 9961426 (1999-12-01), None
patent: WO 0012074 (2000-03-01), None
patent: WO 0059904 (2000-03-01), None
CRC handbook p. 9-26-43 (2002).*
Cecil textbook of Medicine, Saunders Co. p. 1395-1396.*
Adams et al. “Imidazole Compounds . . . ” CA 128:201066 (1998).
De Clerck et al. (1981).Throm. Res23:1-12.
Dukic et al. (1997).Arch. Pharm330:25-28.
Eyers, P.A. et al., “Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution”,Chem and Biol(1995) 5:321-328.
Fisher, “Physical chemical properties and local anesthetic results of an ether substitute of procaine” CA 67:10051 (1996).
Gassman, P. G., “A General Method for the Synthesis of Indoles,” J. Am. Chem. Soc., (1974) 96(17): 5495-5508.
International Search Report dated Jul. 29, 1999.
Jiang, Y. et al., “Characterization of the structure and function of a new mitogen-activated protein kinase (p38β)”J Biol Chem(1996) 271:17920-17926.
Kumar, S. et al. “Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles”,Biochem Biophys Res Comm(1997) 235:533-538.
Li, Z. et al. “The primary structure of p38γ: a new member of p38 group of MAP kinases”,Biochem Biophys Res Comm(1996) 228:334-340.
Mittendorf et al. “Preparation of Bis-Benzimidazoles . . . ” CA 132:265195 (2000).
Murai, Y., et al., “Synthesis of 4-, 5-, 6- and 7-Substituted N-Tosylindoles from Substituted Anilines,”Heterocycles, (1992) 34(5):1017-1029.
Muro et al. “Dihydrobenzofuran Derivatives” CA 88:169949 (1978).
Nakai et al. (1994).CA121:222012.
Nakai et al. (1994).CA121:221997.
Oelschlaeger et al. (1988).CA109:73387.
Ogawa et al. “Studies on Positive Inotropic . . . ” CA 110:57613 (1988).
Otsuka Pharm. (1983).CA100:51465.
Otsuka Pharm. (1983).CA100:34414.
Otsuka Pharm. (1984).CA100:68187.
Patani et al. “Bioisosterism: A Rational Approach in Drug Design” Chem. Rev. 96:3147-3176 (1996).
Societe Des Usine Chemiques “Anticancerous 2-Substituted . . . ” CA 77:34584 (1968).
Stein, B. et al., “p38-2, a novel mitogen-activated protein kinase with distinct properties”,J Biol Chem(1997) 272:19509-19517.
Tamada et al. “Preparation of Benzoheterocycle . . . ” CA 111:153834 (1989).
Von Strandtmann. (1971).CA80:82713.
Wang, X.S., et al., “Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase”,J Biol Chem(1997) 272:23668-23674.
Wang, Y. et al., “Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family”,J Biol Chem(1998) 273:2161-2168.

Affiliated with

Also associated with

Rating

Indole-type derivatives as inhibitors of p38 kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole-type derivatives as inhibitors of p38 kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole-type derivatives as inhibitors of p38 kinase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3407363